Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry – The New York Times

Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients’ reach.

Source: Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry – The New York Times

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s